Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

Market Overview

0.0000 0 (%)

Data as of Dec 14, 2019

Prev. Close
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade ROSG stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix Eddie StaleyThu, 26 Apr 2018 13:05:42 -0500
Rosetta Genomics Ltd.: Sabby Healthcare Master Fund, Ltd. (10%+) Buys 119,761 @ Avg Price: $0.42 (Form4) Charles GrossFri, 16 Mar 2018 09:30:25 -0500
Shares Of Penny Stock Rosetta Genomics Up 14.8% Following News Co. Failed To Winn Shareholder Approval For Merger With Genoptix Paul QuintaroMon, 26 Feb 2018 15:45:08 -0500
Rosetta Genomics Fails to get Shareholder Approval for the Merger with Genoptix Paul QuintaroMon, 26 Feb 2018 08:04:14 -0500
Barrington Research Downgrades Rosetta Genomics to Market Perform Eddie StaleyMon, 18 Dec 2017 11:32:27 -0500
33 Biggest Movers From Friday Lisa LevinMon, 18 Dec 2017 05:45:42 -0500
Mid-Afternoon Market Update: Dow Surges Over 150 Points; Longfin Shares Spike Higher Lisa LevinFri, 15 Dec 2017 14:33:14 -0500
30 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 15 Dec 2017 12:30:28 -0500
Mid-Day Market Update: ShiftPixy Gains Following Q4 Results; Verastem Shares Plummet Lisa LevinFri, 15 Dec 2017 12:19:25 -0500
Mid-Morning Market Update: Markets Open Higher; Adobe Earnings Top Expectations Lisa LevinFri, 15 Dec 2017 10:11:12 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Rosetta Announces That Completion of Genoptix Transaction Uncertain ACCESSWIREMay 29, 2018
Nasdaq Hearing Panel Determined to Delist Shares of Rosetta Genomics from Nasdaq Stock Market Effective May 22, 2018 ACCESSWIREMay 18, 2018
Rosetta Receives an Additional Delisting Notice from Nasdaq ACCESSWIREMay 07, 2018
Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix ACCESSWIREApr 26, 2018
Shareholder Meeting Adjourned to April 26, 2018 ACCESSWIREApr 17, 2018
Rosetta Announces Resignation of CEO ACCESSWIREApr 10, 2018
Action Required Before Potential Bankruptcy ACCESSWIREApr 10, 2018
Rosetta Genomics Urges Shareholders to Vote FOR the Proposed Merger with Genoptix ACCESSWIREApr 05, 2018
Genoptix Enters into Agreement to Market and Distribute Rosetta Genomics' Testing Services Worldwide ACCESSWIREMar 13, 2018
Rosetta Sets a New Date for Shareholder Meeting to Approve Genoptix Merger ACCESSWIREMar 12, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Rosetta Genomics - Genoptix tie-up terminated Seeking AlphaFeb 26, 2018
Rosetta Genomics down 16% on failure to get enough shareholder support for Genoptix merger Seeking AlphaFeb 02, 2018
Dec. —— Forum Update: 'Merry Christmas' Edition GuruFocusDec 22, 2017
2017 YTD worst losers - healthcare Seeking AlphaDec 22, 2017
Genoptix to acquire Rosetta Genomics for $10M Seeking AlphaDec 15, 2017
Stocks to watch next week Seeking AlphaDec 02, 2017
Rosetta Genomics shareholders OK 12-fold reduction in number shares; post-split trading commences tomorrow; shares ease 7% Seeking AlphaMar 16, 2017
Rosetta Genomics to reverse split shares 1:12 Seeking AlphaMar 13, 2017
Rosetta to raise $5M via equity and convertible debt; shares down 18% Seeking AlphaNov 23, 2016
Rosetta Genomics inks deal to develop test to predict response to Bristol-Myers cancer drug Opdivo Seeking AlphaNov 21, 2016
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q2 2017	EST	Actual	Surprise
EPS:	Expected 2017-10-10
Rev:	Expected 2017-10-10

	EST	Actual	Surprise
EPS:	Expected
Rev:	Expected

Brokerage Center

Compare All Online Brokerages

Book A Demo

Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo